Some pharmacokinetic parameters and dosage regimens for a long-acting formulation of oxytetracycline in 6- to 8-month-old male calves

Veterinary Research Communications

Volumn 22, Issue 8, 1998, Pages 533-544

  Kumar, R ^a   Malik, J K ^b  

^a RAJASTHAN AGRICULTURAL UNIVERSITY   (India)

^b INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Calves; Dosage regimen; Oxytetracycline; Pharmacokinetics

Indexed keywords

ANTIBIOTIC AGENT; OXYTETRACYCLINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CATTLE; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG METABOLISM; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CATTLE; CROSS-OVER STUDIES; HALF-LIFE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; OXYTETRACYCLINE;

ANIMALIA; BOS TAURUS;

EID: 0032449747     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006193703979     Document Type: Article

References (47)

1. Ames, T.R., Larson, V.L. and Stowe, C.M., 1983. Oxytetracycline concentrations in healthy and diseased calves. American Journal of Veterinary Research, 44, 1354-1357
2. Arret, B., Johnson, D.P. and Kirshbaum, A., 1971. Outline of details for microbiological assay of antibiotics: second revision. Journal of Pharmaceutical Science, 60, 1689-1694
3. Baggot, J.D., 1977. Principles of Drug Disposition in Domestic Animals. The Basis of Veterinary Clinical Pharmacology, (W.B. Saunders and Co., Philadelphia)
4. Baggot, J.D., 1980. Distribution of antimicrobial agents in normal and diseased animals. Journal of the American Veterinary Medical Association, 176, 1085-1090
5. Bauer, F. and Seeger, K., 1979. Chemotherapie bakterieller Infektionen der Haustiere. In: H. Blobel and Th. Schliesser (eds), Hand-buch der bakterieller Infektionen der Tiere, (Gustav Fischer, Jena), 347-552
6. Benet, L.Z., Mitchell, J.R. and Lewis, B.S., 1990. Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination. In: A.G. Gilman, Th.W. Rall, A.S. Nies and P. Taylor (eds), The Pharmacological Basis of Therapeutics, (Pergamon Press, New York), 3-32
7. Breeze, R.G. and Magonigle, R.A., 1979. A long-acting tetracycline for treatment of Pasteurella pneumonia in calves. Bovine Practice, 14, 15-17
8. Bywater, R.J., 1991. Veterinary Applied Pharmacology and Therapeutics, (Baillière-Tindall, London)
9. Cornwell, R.L., 1980. Evaluation of a long-acting injectable oxytetracycline. Modern Veterinary Practice, 61, 945-947
10. Craig, W.A. and Gudmundsson, S., 1991. The postantibiotic effect. In: V. Lorian (ed.), Antibiotics in Laboratory Medicine, (Williams and Wilkins, Baltimore), 403-431
11. Cross, A.S., Sadoff, J.C., Kelly, N., Bernton, E. and Femski, P., 1989. Pretreatment with recombinant murine tumor necrosis factor/cachectin and murine interleukin-1α protects mice from lethal bacterial infection. Journal of Experimental Medicine, 169, 2021-2027
12. Cornwell, R.L., 1980. Evaluation of a long-acting injectable oxytetracycline. Modern Veterinary Practice, 61, 945-947
13. Davey, L.A., Ferber, M.T. and Kaye, B., 1985. Comparison of the serum pharmacokinetics of a long-acting and a conventional oxytetracycline injection. Veterinary Record, 117, 426-429
14. Garrod, L.P., Lambert, H.P., O'Grady, F. and Waterworth, P.M., 1973. Antibiotic and Chemotherapy, (Churchill Livingstone, Edinburgh)
15. Gerber, A.U. and Craig, W.A., 1981. Growth kinetics of respiratory pathogens after short exposures to ampicillin and erythromycin in vitro. Journal of Antimicrobial Chemotherapy, 8(Suppl. C), 81-91
16. Havell, E.A., 1989. Evidence that tumor necrosis factor has an important role in antibacterial resistance. Journal of Immunology, 143, 2894-2899
17. Ilemobade, A.A., Gyang, E.O., Bida, S.A. and Addo, P.B., 1979. Cure of Dermatophilus congolensis infection in cattle by long-acting oxytetracycline. Research in Veterinary Science, 27, 302-305
18. Janzen, F.D. and McManus, R.F., 1980. Observation on the use of a long-acting oxytetracycline for in-contact prophylaxis of undifferentiated bovine respiratory disease in feed-lot steers under Canadian conditions. Bovine Practice, 15, 87-90.
19. Koritz, G.D., 1984. Relevance of peak and trough concentration to antimicrobial drug therapy. Journal of American Veterinary Medical Association, 185, 1072-1075
20. Kunin, C.M., 1966. Clinical pharmacology of the new penicillins I. The importance of serum protein binding in determining antimicrobial activity and concentration in serum. Clinical Pharmacology and Therapeutics, 7, 166-179
21. Lam, F.C., Hung, C.T. and Perrier, D.G., 1985. Estimation of variance for harmonic mean half-lives. Journal of Pharmaceutical Sciences, 74, 229-231
22. Lambert, H.P. and O'Grady, F.W., 1992. Antibiotic and Chemotherapy, (Churchill Livingstone, Edinburgh)
23. Mackenzie, F.M. and Gould, I.M., 1993. The postantibiotic effect. Journal of Antimicrobial Chemotherapy, 32, 519-537
24. Magonigle, R.A., Simpson, J.E. and Frank, F.W., 1978. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis. American Journal of Veterinary Research, 39, 1407-1410
25. Meijer, L.A., Ceyssens, K.G.F., de Jong, W.Th. and de Greve, B.I.J.A.C., 1993. Three phase elimination of oxytetracycline in veal calves; the presence of an extended terminal phase. Journal of Veterinary Pharmacology and Therapeutics, 16, 214-222
26. Mercer, H.D., Teske, R.H., Long, P.E. and Showalter, D.H., 1978. Drug residues in food animals II, plasma and tissue kinetics of oxytetracycline in young cross-bred swine. Journal of Veterinary Pharmacology and Therapeutics, 1, 119-128
27. Mevius, D.J., Nouws, J.F.M., Breukink, H.J., Vree, T.B., Driessens, F. and Verkaik, R., 1986. Comparative pharmacokinetics, bioavailability and renal clearance of five parenteral oxytetracycline-20% formulations in dairy cows. The Veterinary Quarterly, 8, 285-294
28. Nakamura, S., Minami, A., Fugimoto, K. and Kojima, T., 1989. Combination effect of recombinant human interleukin-1α with antimicrobial agents. Antimicrobial Agents and Chemotherapy, 33, 1804-1810
29. Nouws, J.F.M., 1984. Irritation, bioavailability, and residue aspects of ten oxytetracycline formulations administered intramuscularly to pigs. The Veterinary Quarterly, 6, 80-84
30. Nouws, J.F.M., Breukink, H.J., Binkhorst, G.J., Lohuis, J., van Lith, P., Mevius, D.J. and Vree, T.B., 1985. Comparative pharmacokinetics and bioavailability of eight parenteral oxytetracycline-10% formulations in dairy cows. The Veterinary Quarterly, 7, 306-314
31. Pandey, V.S. and Mwamba, T., 1977. Successful therapy of balantidiosis of pigs with acetarsol and oxytetracycline. Veterinary Parasitology, 3, 189-193
32. Pilloud, M., 1973. Pharmacokinetics, plasma protein binding and dosage of oxytetracycline in cattle and horses. Research in Veterinary Science, 15, 224-230
33. Powers, T.E., Verma, K.J. and Powers, J.D., 1984. Selecting therapeutic concentrations: minimum inhibitory concentrations vs subminimum or supraminimum inhibitory concentrations. Journal of American Veterinary Medical Association, 185, 1062-1067
34. Prasad, S., Jayachandran, C. and Singh, M.K., 1987. Pharmacokinetics of oxytetracycline in dairy cows. Indian Journal of Animal Science, 57, 106-110
35. Sadekar, R.D., 1993. Pharmacokinetics and dosage regimen of intramuscular oxytetracycline in adult buffaloes. Indian Veterinary Journal, 70, 578-579
36. Schifferli, D., Galeazzi, R.L., Nicolet, J. and Wanner, M., 1982. Pharmacokinetics of oxytetracycline and therapeutic implications in veal calves. Journal of Veterinary Pharmacology and Therapeutics, 5, 247-257
37. Singh, M.K., Jayachandran, C., Singh, S.D. and Banerjee, N.C., 1988. Pharmacokinetics and dosage regimens of oxytetracycline following intramuscular administration in the buffaloes. Indian Veterinary Journal, 65, 28-32
38. Steel, R.L.D. and Torrie, S.H., 1980. Principles and Procedures of Statistics: A Biometric Approach, (McGraw-Hill, New York)
39. TerHune, T.N. and Upson, D.W., 1989. Oxytetracycline pharmacokinetics, tissue depletion and toxicity after administration of a long-acting preparation at double the label dosage. Journal of the American Veterinary Medical Association, 194, 911-916
40. Toutain, P.L. and Raynaud, J.P., 1983. Pharmacokinetics of oxytetracycline in young cattle: comparison of conventional vs long-acting formulations. American Journal of Veterinary Research, 44, 1203-1209
41. Varma, K.J. and Paul, B.S., 1983. Pharmacokinetics and plasma protein binding (in vitro) of oxytetracycline in buffalo (Bubalus bubalis). American Journal of Veterinary Research, 44, 497-499
42. Xia, W., Gyrd-Hansen, N. and Nielsen, P., 1983. Comparison of pharmacokinetic parameters for two oxytetracycline preparations in pigs. Journal of Veterinary Pharmacology and Therapeutics, 6, 113-120
43. Yamaoka, K., Nakagawa, T. and Uno, T., 1978a. Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 6, 547-558
44. Yamaoka, K., Nakagawa, T. and Uno, T., 1978b. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165-175
45. Yamaoka, K., Tanigawara, Y., Nakagawa, T. and Uno, T., 1981. A pharmacokinetic analysis program (MULTI) for microcomputer. Journal of Pharmacobio-Dynamics, 4, 879-885
46. Zhanel, G.G. and Craig, W.A., 1994. Pharmacokinetic concentrations to postantibiotic effects: focus on aminoglycosides. Clinical Pharmacokinetics, 27, 377-392
47. Zhanel, G.G., Hoban, D.J. and Harding, G.K.M., 1991. The postantibiotic effect: a review of in vitro and in vivo data. DICP Annals of Pharmacotherapy, 25, 153-163